efavirenzemtricitabinetenofovir sold brand name atripla among others fixeddose combination antiretroviral medication used treat contains efavirenz emtricitabine tenofovir used together antiretroviral taken common side effects include headache trouble sleeping sleepiness serious side effects may include high blood lactate levels psychiatric symptoms enlargement used used first trimester pregnancy harm baby may efavirenzemtricitabinetenofovir approved medical use united states european union world health organizations list essential efavirenzemtricitabinetenofovir available generic efavirenzemtricitabinetenofovir indicated treatment people shown strong hypersensitivity efavirenz take efavirenzemtricitabinetenofovir drugs contraindicated voriconazole ergot derivative drugs benzodiazepines midazolam triazolam calcium channel blocker bepridil cisapride pimozide st johns wort hypericum perforatum breastfeeding also common side effects efavirenzemtricitabinetenofovir tiredness dizziness gastrointestinal distress skin discoloration severe side effects hallucinations sleeplessness recommended dosage efavirenzemtricitabinetenofovir one tablet bedtime side effects reduced taken empty stomach people kidney liver problems take one tablet mouth day however people whose crcl levels less follow dosage instead patients prescribed drug components fixeddose combinations adjusting tdf ftc doses according patients crcl medications taken efavirenzemtricitabinetenofovir include bepridil midazolam pimozide triazolam ergot derivatives additionally st johns wort known reduce effectiveness efavirenzemtricitabinetenofovir resulting increased viral load possible resistance efavirenz nonnucleoside reverse transcriptase inhibitor nnrti emtricitabine nucleoside reverse transcriptase inhibitor nrti tenofovir nucleotide reverse transcriptase inhibitor classified ntrti three drugs work combination target hiv reverse transcriptase protein three ways reduces viruss capacity combination studies synergistic antiviral effects observed emtricitabine efavirenz efavirenz tenofovir emtricitabine efavirenzemtricitabinetenofovir approved united states oncedaily tablet treat hiv main advantage new drug could taken daily reduce overall stress antiretroviral equivalent two pill regimen available developing countries price per day gilead sciences licensed patents covering emtricitabinetenofovir medicines patent merck co makes efavirenz available developing countries reduced first multiclass antiretroviral drug available united states represents first collaboration two us pharmaceutical companies combine patented antihiv drugs one much developing world marketing distribution handled merck atripla pink filmcoated tablet impressed one sidecitation needed httpsenwikipediaorgwikiefavirenzemtricitabinetenofovir